Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05199285
Title	Nivolumab and Ipilimumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Liver Cancer
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Academic and Community Cancer Research United
Indications	Advanced Solid Tumor
Therapies	Ipilimumab + Nivolumab
Age Groups:	senior \| adult
Covered Countries	USA

Filter rows:

Showing 1 to 6 of 6 entries

Facility	Status	City	State	Zip	Country	Details
Emory University Hospital/Winship Cancer Institute	NOT_YET_RECRUITING	Atlanta	Georgia	30322	United States	Details
Mayo Clinic in Rochester	NOT_YET_RECRUITING	Rochester	Minnesota	55905	United States	Details
Rutgers Cancer Institute of New Jersey	RECRUITING	New Brunswick	New Jersey	08903	United States	Details
University of Alabama- Birmingham	RECRUITING	Birmingham	Alabama	35233	United States	Details
University of Miami Miller School of Medicine-Sylvester Cancer Center	RECRUITING	Miami	Florida	33136	United States	Details
Vanderbilt University/Ingram Cancer Center	RECRUITING	Nashville	Tennessee	37232	United States	Details

Showing 1 to 6 of 6 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field